Setting the standard through dynamic genomic technology platform, improving patient outcomes AURORA, Colo., /PRNewswire/ -- ...

Scientists' yearlong study on Antarctic microbial communities reveals how climate change alters bacterial and phytoplankton ...

Artisan Partners, an investment management company, released its “Artisan Small Cap Fund” fourth quarter 2024 investor letter ...

The global electrophoresis market is set to witness substantial growth, with its valuation projected to rise from USD 2,268.8 million in 2023 to USD 3,523.50 million by 2033. This expansion reflects a ...

An ambitious start-up embodies new optimism that artificial intelligence can turbocharge scientific discovery.

Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based ... Chinese officials banned imports of its genetic sequencing equipment following President Trump's latest tariffs.

The agriculture biologicals testing market was valued at $2.7 billion in 2022, and is estimated to reach $5.5 billion by 2032, growing at a CAGR of 7 ...

Discover how AI is shaping the future of forensic science, from crime scene reconstruction to DNA analysis. Explore the ...

A new collaboration between the MHRA and Barts Health NHS Trust has led to introduction a new DNA sequencing technology ...

University at Albany researchers at the RNA Institute are pioneering new methods for designing and assembling DNA ...

DNA sequencing is any chemical, enzymatic or technological procedure for determining the linear order of nucleotide bases in DNA. Sanger sequencing by replicative synthesis in the presence of ...

Illumina will seek to cut $100 million in expenses by the end of this fiscal year as it plans to deal with a loss of revenue ...